Chemomab Therapeutics CMMB
NASDAQ CMMB
$2.16 +0.09 (+4.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Change in Receivables (2018 - 2019)

Chemomab Therapeutics' (CMMB) quarterly Change in Receivables came in at -$3.8 million in Q4 2019, down 163.99% YoY from $5.9 million in Q4 2018, and down 977.49% on a QoQ basis from -$351000.0 in Q3 2019.

Chemomab Therapeutics (CMMB) Change in Receivables (2018 - 2019) Analysis & Trends

Chemomab Therapeutics (CMMB) has 2 years of Change in Receivables data on file, last reported at -$3.8 million in Q4 2019.

  • Quarterly Change in Receivables fell 163.99% year-over-year to -$3.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$724000.0 (changed N/A YoY) and the FY2019 annual result came in at -$2.3 million, down 165.93% from the prior year.
  • Change in Receivables fell to -$3.8 million in Q4 2019, from -$351000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $5.9 million in Q4 2018 to a low of -$3.8 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -53.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 117.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 31.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 94.29 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 37.16 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Chemomab Therapeutics 13.62 Mn 3.25 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 -3.78 Mn
Dec 31, 2019 -3.78 Mn
Sep 30, 2019 -351,000.00
Sep 30, 2019 -351,000.00
Dec 31, 2018 5.91 Mn
Dec 31, 2018 5.91 Mn
Sep 30, 2018 -2.50 Mn
Sep 30, 2018 -2.50 Mn